Epidemiology of Vector-Borne Diseases (3rd Edition)

A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Public Health Microbiology".

Deadline for manuscript submissions: closed (31 January 2025) | Viewed by 2593

Special Issue Editor

Special Issue Information

Dear Colleagues,

This Special Issue is the continuation of our 2022 Special Issue “Epidemiology of Vector Born Diseases 2.0”.

Vector-borne infectious diseases, occuring due to parasites (malaria, leishmaniasis, trypanosomiasis, filariasis, etc.), viruses (chikungunya, dengue, phlebovirus, etc.) or bacteria (bartonellosis, Lyme disease), represent a significant fraction of the global infectious disease burden; indeed, nearly half of the world’s population is infected with at least one type of vector-borne pathogen. An understanding of the molecular basis of interactions between these pathogens and their hosts (vertebrate and invertebrate) would provide a rationale for developing new tools that aim at interrupting the transmission process and/or control infection.

The goal of this proposed Special Issue, entitled “Epidemiology of Vector-Borne Diseases”, is to present recent advances in the knowledge regarding etiology, pathogenesis, and transmission processes and its translation into tools for detecting and combating these diseases. Original articles, reviews, viewpoints, and perspectives focusing on new technological developments and breakthroughs in vector-borne diseases are welcome. Potential topics include, but are not limited to, the biochemistry and molecular biology of pathogens, vectors and their interactions; the application of new technology to vector-borne disease diagnosis; novel approaches for blocking disease transmission; studies on the determinants of vectorial competence and prevalence of infections in the field; microbiological or metagenomic analyses of microbiomes associated with vectors, their interaction with pathogens, vaccines, drug development, and drug resistance.

Manuscripts dealing with systemic review will only be acceptable in rare cases.

Dr. Denis Sereno
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • vector-borne infectious diseases
  • malaria
  • leishmaniasis
  • trypanosomiasis
  • filariasis
  • molecular basis of interactions
  • pathogens
  • vaccines
  • drug development and resistance

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Other

12 pages, 1928 KiB  
Article
Using Catalytic Models to Interpret Age-Stratified Lyme Borreliosis Seroprevalence Data: Can This Approach Help Provide Insight into the Full Extent of Human Infection Occurring at the Population Level?
by Andrew Vyse and Emily Colby
Microorganisms 2024, 12(12), 2638; https://doi.org/10.3390/microorganisms12122638 - 19 Dec 2024
Viewed by 533
Abstract
Diagnosis of Lyme borreliosis (LB) is prone to under ascertainment with the true extent of infection unknown. Cross sectional age-stratified population-based serological survey data may provide insight into this issue. Using data from a previously published Dutch seroprevalence study, we describe the application [...] Read more.
Diagnosis of Lyme borreliosis (LB) is prone to under ascertainment with the true extent of infection unknown. Cross sectional age-stratified population-based serological survey data may provide insight into this issue. Using data from a previously published Dutch seroprevalence study, we describe the application of catalytic models to make estimates of the annual extent of LB infection. A common assumption when using catalytic models is that IgG is protective and immunity is lifelong. However, human IgG produced in response to natural LB infection does not protect against subsequent infection and its duration may be limited. Individuals were thus assumed to be continually susceptible to LB infection, with a range of scenarios used that varied the length of time that IgG may remain detectable, from 5 years post-infection to lifelong. The possibility that IgG may remain detectable for longer in adults than in children was also explored. Estimates for the annual number of LB infections occurring in the Dutch population ranged from 163,265 (95%CI 130,150–201,723) when assuming IgG remains detectable for only 5 years post-infection to 26,209 (95%CI 17,159–36,557) when assuming IgG is lifelong. Full article
(This article belongs to the Special Issue Epidemiology of Vector-Borne Diseases (3rd Edition))
Show Figures

Figure 1

Other

Jump to: Research

6 pages, 200 KiB  
Perspective
Chagas Disease across the Ages: A Historical View and Commentary on Navigating Future Challenges
by Denis Sereno, Bruno Oury and Mario J. Grijalva
Microorganisms 2024, 12(6), 1153; https://doi.org/10.3390/microorganisms12061153 - 6 Jun 2024
Cited by 2 | Viewed by 1539
Abstract
Chagas disease, discovered over a century ago, continues to pose a global health challenge, affecting millions mainly in Latin America. This historical review with commentary outlines the disease’s discovery, its evolution into a global concern due to migration, and highlights significant advances in [...] Read more.
Chagas disease, discovered over a century ago, continues to pose a global health challenge, affecting millions mainly in Latin America. This historical review with commentary outlines the disease’s discovery, its evolution into a global concern due to migration, and highlights significant advances in diagnostics and treatment strategies. Despite these advancements, the paper discusses ongoing challenges in eradication, including vector control, congenital transmission, the disease’s asymptomatic nature, and socioeconomic barriers to effective management. It calls for a multidisciplinary approach, enhanced diagnostics, improved treatment accessibility, and sustained vector control efforts. The review emphasizes the importance of global collaboration and increased funding to reduce Chagas disease’s impact. Full article
(This article belongs to the Special Issue Epidemiology of Vector-Borne Diseases (3rd Edition))
Back to TopTop